Tumor Biology (Apr 2019)

Clinical–pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours

  • Maximino Redondo,
  • Cristina Abitei,
  • Teresa Téllez,
  • Rafael Fúnez,
  • Teresa Pereda,
  • Isabel Rodrigo,
  • Ana M Betancourt,
  • Marilina García-Aranda,
  • Antonio Rueda,
  • Rafael Cayetano Martínez García,
  • María Manuela Morales Suarez-Varela,
  • Iñaki Zabalza,
  • Matilde Sánchez del Charco,
  • Juan José Borrero Martín,
  • Raimundo García del Moral,
  • Antonio Escobar,
  • JoséMaría Quintana,
  • Francisco Rivas-Ruiz,

DOI
https://doi.org/10.1177/1010428319835684
Journal volume & issue
Vol. 41

Abstract

Read online

We investigate the clinical and pathological features related to variations in colorectal tumour apoptosis, proliferation and angiogenesis and the influence of the latter in short-term mortality (2 years); 551 tumour samples from a prospective cohort of patients with colorectal cancer were examined and tumour biology markers were determined as follows: percentage of apoptotic cells, by the terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling technique; Ki-67 antigen, as a cell proliferation marker and density of microvessels (as a marker of angiogenesis). An increase in the percentage of cellular apoptosis is significantly related to the presence of poorly differentiated tumours, with vascular invasion (p < 0.001). The CD105 angiogenesis marker is not related to any clinical–pathological parameter except that of higher frequency in older patients (p = 0.03). Ki-67 is more frequently expressed in tumours with less nervous invasion (p = 0.05). Neither apoptosis nor angiogenesis present any significant association with short-term survival. The only marker clearly related to 2-year survival is Ki-67, which is shown to be a good prognostic factor in the multivariate analysis (hazard ratio = 0.49; 95% confidence interval = 0.27–0.90). Therefore, in a prospective cohort of colorectal cancer patients, only Ki-67 is a marker of good prognosis in short-term follow-up.